Search Results - "KALIKAKI, A"

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC by Kalikaki, A, Koutsopoulos, A, Trypaki, M, Souglakos, J, Stathopoulos, E, Georgoulias, V, Mavroudis, D, Voutsina, A

“…In non-small-cell lung cancer (NSCLC), epidermal growth factor receptor ( EGFR ) and K-RAS mutations of the primary tumour are associated with responsiveness…”
Get full text

P-028Analysis of KRAS and NRAS mutations in Greek patients with metastatic Colorectal Cancer (mCRC) on the registry of the Gastro-intestinal Cancer Study Group (GIC-SG) by Souglakos, J, Saridaki, Z, Gouges, N, Voutsina, A, Tzardi, M, Kalikaki, A, Sfakianaki, M, Athanasiadis, A, Xynos, E, Boukovinas, I

Get full text

Long-term clinical benefit from salvage EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer patients with EGFR wild-type tumors by Koinis, F., Voutsina, A., Kalikaki, A., Koutsopoulos, A., Lagoudaki, E., Tsakalaki, E., Dermitzaki, E. K., Kontopodis, E., Pallis, A. G., Georgoulias, V., Kotsakis, A.

“…Background Erlotinib has been approved for the management of NSCLC patients after failure of the first or subsequent line of chemotherapy. Although the…”
Get full text

MP-10.16 Cystatin-C, Interleukin-18 and N-GAL Levels as Biomarkers of Inflammatory Response After Extracorporeal Shock Wave Lithotripsy by Nomikos, M, Kardakos, I, Kalikaki, A, Karyotis, I, Serafetinides, E, Tzortzis, V, Stefanidis, I, Delakas, D, Melekos, M

Get full text

P17 EGFR, K-RAS and HER2 mutations as predictive factors for gefitinib sensitivity in non-small cell lung cancer (NSCLC) by Voutsina, A, Kalikaki, A, Ampatziadis-Michailidis, Y, Souglakos, J, Koytsopoylos, A, Trypaki, M, Pallis, A, Stathopoylos, S, Mavroudis, D, Georgoulias, V

Get full text

Next generation sequencing identifies actionable mutations in EGFR-wild type and KRAS mutant non-small cell lung cancer patients by Voutsina, A., Kalikaki, A., Koutsopoulos, A., Sfakianaki, M., Trypaki, M., Tsakalaki, E., Agelaki, S., Georgoulias, V., Mavroudis, D.

Get full text

P-028 Analysis of KRAS and NRAS mutations in Greek patients with metastatic Colorectal Cancer (mCRC) on the registry of the Gastro-intestinal Cancer Study Group (GIC-SG) by Souglakos, J., Saridaki, Z., Gouges, N., Voutsina, A., Tzardi, M., Kalikaki, A., Sfakianaki, M., Athanasiadis, A., Xynos, E., Boukovinas, I.

Get full text

'Classical' but not 'other' mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer by PALLISL, A. G, VOUTSINA, A, CEORGOULIAS, V, KALIKAKI, A, SOUGLAKOS, J, BRIASOULIS, E, MURRAY, S, KOUTSOPOULOS, A, TRIPAKI, M, STATHOPOULOS, E, MAVROUDIS, D

“…'Classical' mutations in the EGFR tyrosine kinase domain (exons 18, 19 and 21) have been associated with sensitivity to tyrosine kinase inhibitors (TKIs) in…”
Get full text

Association of PIK3CA kinase domain mutations with poor prognosis in operable breast cancer by Voutsina, A., Kalikaki, A., Mitsi, V., Stathopoulos, E., Georgoulias, V., Mavroudis, D.

“…Abstract only…”
Get full text

Impact of KRAS, BRAF , and PIK3CA mutations, PTEN, AREG, and EREG expression, and skin rash in metastatic colorectal cancer patients treated with cetuximab-containing salvage treatment by Saridaki, Z., Tzardi, M., Papadaki, C., Sfakianaki, M., Pega, F., Kalikaki, A., Tsakalaki, E., Mavroudis, D., Georgoulias, V., Sougklakos, I.

“…Abstract only 445 Background: To investigate the predictive significance of KRAS exon 2, BRAF V600E, PIK3CA exon 9 and 20 mutational status, AREG- EREG mRNA…”
Get full text

Correlation of gefitinib efficacy and detection of new EGFR mutation variants in pre-treated patients (pts) with advanced non- small cell lung cancer (NSCLC) by Pallis, A., Voutsina, A., Kalikaki, A., Koutsopoulos, A., Souglakos, J., Christophylakis, C., Kentepozidis, N., Giassas, S., Mavroudis, D., Georgoulias, V.

“…Abstract only 18062 Background: The efficacy of tyrosine kinase inhibitors (TKIs) of EGFR is associated with well characterized mutations on the exons 18, 19…”
Get full text

Acute febrile neutrophilic dermatosis (Sweet's syndrome) with erythema nodosum and anterior scleritis. A case report by Mazokopakis, Elias, Kalikaki, Antonia, Stathopoulos, Efstathios, Vrentzos, George, Papadakis, John A.

“…A 53‐year‐old Greek housewife was admitted to hospital because of painful erythematous lesions on the lower (Fig. 1) and upper (Fig. 2) extremities in…”
Get full text

Effects of anti-TNF therapy on endothelial function and intima-media thickness of common carotid artery in patients with rheumatoid arthritis by Siakka, P, Kalikaki, A, Pagonidis, K, Sidiropoulos, P, Kritikos, H, Ganotakis, E, Tsetis, D, Boumpas, DT

Get full text

Effect of antihypertensive treatment on plasma fibrinogen and serum HDL levels in patients with essential hypertension by Papadakis, John A, Mikhailidis, Dimitri P, Vrentzos, George E, Kalikaki, Antonia, Kazakou, Irene, Ganotakis, Emmanuel S

“…The influence of hypertension, and its treatment, on circulating lipid and fibrinogen (Fib) concentrations in patients with essential hypertension was…”
Get more information

W01.21 Effects of anti-TNF therapy on endothelial function and intima-media thickness of common carotid artery in patients with rheumatoid arthritis (RA) by Ganotakis, E., Siakka, P., Kalikaki, A., Pagonidis, K., Sidiropoulos, P., Kritikos, H., Tsetis, D., Boumpas, D.

Get full text